KR20230083272A - 신경병성 통증의 국소 치료에 사용하기 위한 메피라민 - Google Patents

신경병성 통증의 국소 치료에 사용하기 위한 메피라민 Download PDF

Info

Publication number
KR20230083272A
KR20230083272A KR1020237008699A KR20237008699A KR20230083272A KR 20230083272 A KR20230083272 A KR 20230083272A KR 1020237008699 A KR1020237008699 A KR 1020237008699A KR 20237008699 A KR20237008699 A KR 20237008699A KR 20230083272 A KR20230083272 A KR 20230083272A
Authority
KR
South Korea
Prior art keywords
neuropathy
mepyramine
neuropathic pain
topical composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237008699A
Other languages
English (en)
Korean (ko)
Inventor
셀린느 그레코
패트릭 델마스
Original Assignee
아시스땅스 퍼블리끄-오삐또 드 빠리
쌩뜨레 나티오날 데 라 르세르쉬 생띠끄
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아시스땅스 퍼블리끄-오삐또 드 빠리, 쌩뜨레 나티오날 데 라 르세르쉬 생띠끄 filed Critical 아시스땅스 퍼블리끄-오삐또 드 빠리
Publication of KR20230083272A publication Critical patent/KR20230083272A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020237008699A 2020-09-11 2021-09-10 신경병성 통증의 국소 치료에 사용하기 위한 메피라민 Pending KR20230083272A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306009.0 2020-09-11
EP20306009.0A EP3967308A1 (en) 2020-09-11 2020-09-11 Mepyramine for use in the topical treatment of neuropathic pain
PCT/EP2021/074906 WO2022053598A1 (en) 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
KR20230083272A true KR20230083272A (ko) 2023-06-09

Family

ID=72615785

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237008699A Pending KR20230083272A (ko) 2020-09-11 2021-09-10 신경병성 통증의 국소 치료에 사용하기 위한 메피라민

Country Status (7)

Country Link
US (1) US20230321059A1 (cg-RX-API-DMAC7.html)
EP (2) EP3967308A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023540355A (cg-RX-API-DMAC7.html)
KR (1) KR20230083272A (cg-RX-API-DMAC7.html)
AU (1) AU2021342331A1 (cg-RX-API-DMAC7.html)
CA (1) CA3191653A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022053598A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026119772A1 (fr) 2024-12-02 2026-06-11 Assistance Publique Hopitaux De Paris Nanoparticules de mepyramine et de squalene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521342D0 (en) * 1985-08-27 1985-10-02 Univ Glasgow Medicament
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain

Also Published As

Publication number Publication date
US20230321059A1 (en) 2023-10-12
WO2022053598A1 (en) 2022-03-17
JP2023540355A (ja) 2023-09-22
EP3967308A1 (en) 2022-03-16
CA3191653A1 (en) 2022-03-17
EP4210699A1 (en) 2023-07-19
AU2021342331A1 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
CA2104873C (en) Compositions and methods of treatment of sympathetically maintained pain
US6559186B1 (en) Compositions and methods of treatment of sympathetically maintained pain
JPH10505864A (ja) 種々の頑固な疾患の治療のための医薬の製造に有用な組成物
JP2003522785A (ja) 眼痛の処置方法
EP3551166B1 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
US20080146672A1 (en) Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
KR102693607B1 (ko) 하지 불안 증후군을 치료하기 위한 치료제
EP2138174A1 (en) Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management
US20230321059A1 (en) Mepyramine for use in the topical treatment of neuropathic pain
KR20250004041A (ko) 삼차 신경통 치료 및 그와 관련된 통증 감소에 사용하기 위한 트리메프라진
JP2001526217A (ja) 血管性頭痛に対する局所麻酔薬の新規な使用
US20080255238A1 (en) Composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
KR20000029647A (ko) 양극성장애의치료방법
JP2000515865A (ja) 過剰攻撃を処置する方法
Siddu Evaluation of Buprenorphine Added to Lignocaine for Post Operative Analgesia After Lower Third Molar Surgery
WO2015199248A1 (ja) 発汗抑制剤
AU2004237943A1 (en) Further therapeutic use of zolpidem
Yosipovitch Itch-an update
HK40015081A (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
US20090239898A1 (en) Further therapeutic use of zolpidem
HK1214156B (en) Therapeutic mirtazapine combinations for use in pain disorders
HK1214156A1 (zh) 用於疼痛病症的治疗性米氮平组合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902